Abstract
The AACR–NCI–EORTC international conference held on 15–19 November 2009 in Boston (MA, USA) was a unique opportunity to discuss basic and translational research and the therapeutic implications in relation to molecular targets in cancer. The conference was divided into plenary and educational sessions, keynote presentations, special lectures, proffered papers and poster sessions. This conference is a joint effort of prestigious organizations (EORTC, NCI and AACR) that have been involved for several years in basic and clinical cancer research. In this report, we will summarize the main topics discussed at this conference.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.